KINOGEN Trademark

Trademark Overview

On Monday, April 25, 2016, a trademark application was filed for KINOGEN with the United States Patent and Trademark Office. The USPTO has given the KINOGEN trademark a serial number of 87012748. The federal status of this trademark filing is REGISTERED as of Tuesday, December 17, 2019. This trademark is owned by Kinogen, LLC. The KINOGEN trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceuticals in the field of hematological disorders, oncology, infectious and auto-immune diseases
kinogen

General Information

Serial Number87012748
Word MarkKINOGEN
Filing DateMonday, April 25, 2016
Status700 - REGISTERED
Status DateTuesday, December 17, 2019
Registration Number5938311
Registration DateTuesday, December 17, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 13, 2016

Trademark Statements

Goods and Servicespharmaceuticals in the field of hematological disorders, oncology, infectious and auto-immune diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 28, 2016
Primary Code005
First Use Anywhere DateMonday, November 4, 2019
First Use In Commerce DateMonday, November 4, 2019

Trademark Owner History

Party NameKinogen, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressLos Angeles, CA 90035
Party NameKinogen, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressLos Angeles, CA 90035
Party NameKinogen, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLos Angeles, CA 90035

Trademark Events

Event DateEvent Description
Tuesday, December 17, 2019REGISTERED-PRINCIPAL REGISTER
Thursday, November 14, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, November 13, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, November 13, 2019STATEMENT OF USE PROCESSING COMPLETE
Thursday, November 7, 2019USE AMENDMENT FILED
Thursday, November 7, 2019TEAS STATEMENT OF USE RECEIVED
Thursday, March 21, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 20, 2019EXTENSION 5 GRANTED
Monday, March 18, 2019EXTENSION 5 FILED
Wednesday, March 20, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 18, 2019TEAS EXTENSION RECEIVED
Friday, October 19, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 17, 2018EXTENSION 4 GRANTED
Wednesday, October 17, 2018EXTENSION 4 FILED
Wednesday, October 17, 2018TEAS EXTENSION RECEIVED
Thursday, May 10, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 8, 2018EXTENSION 3 GRANTED
Tuesday, May 8, 2018EXTENSION 3 FILED
Tuesday, May 8, 2018TEAS EXTENSION RECEIVED
Wednesday, September 27, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 25, 2017EXTENSION 2 GRANTED
Monday, September 25, 2017EXTENSION 2 FILED
Monday, September 25, 2017TEAS EXTENSION RECEIVED
Friday, March 17, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 15, 2017EXTENSION 1 GRANTED
Wednesday, March 15, 2017EXTENSION 1 FILED
Wednesday, March 15, 2017TEAS EXTENSION RECEIVED
Tuesday, November 8, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 13, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 13, 2016PUBLISHED FOR OPPOSITION
Wednesday, August 24, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 9, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 9, 2016ASSIGNED TO EXAMINER
Thursday, April 28, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM

Related Keywords

kinogen auto immune diseases infectious oncology field hematological disorders pharmaceuticals